Playback speed
10 seconds
Influenza Hemagglutinin Stem Nanoparticle Vaccine Induces Cross-Group 1 Neutralizing Antibodies in Healthy Adults, Impact of SARS-CoV-2 Variants on Inpatient Clinical Outcome, and Gut Microbiota Derived Symbiotic Formula (SIM01) as a Novel Adjuvant Therapy for COVID‐19
5 views
August 3, 2023
Login to view comments.
Click here to Login